CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer
2021 · Cell Death and Disease · 40 citations
https://doi.org/10.1038/s41419-021-04027-6
D
Donggen Jiang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
280
Citations
10
h-index
11
i10-index
Donggen Jiang is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Prostate Cancer Diagnosis and Treatment & Epigenetics and DNA Methylation. The author has an h-index of 10, co-authored 20 publications.
Papers by this author
worksOverexpression of PFKFB3 promotes cell glycolysis and proliferation in renal cell carcinoma
2022 · BMC Cancer · 34 citations
https://doi.org/10.1186/s12885-022-09183-2
MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer
2021 · Computational and Structural Biotechnology Journal · 30 citations
https://doi.org/10.1016/j.csbj.2021.08.046
Circular RNA circVAMP3 promotes aerobic glycolysis and proliferation by regulating LDHA in renal cell carcinoma
2022 · Cell Death and Disease · 28 citations
https://doi.org/10.1038/s41419-022-04863-0
Additional file 1 of Overexpression of PFKFB3 promotes cell glycolysis and proliferation in renal cell carcinoma
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.18849273
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat